To this end, we have characterized acute EGFR-specific TKI-induced transcriptional reprogramming in vitro with EGFR mutant lung cancer cell lines as well as matched pairs of pre- and on-treatment biopsies of primary EGFR mutant lung tumors. This evidence concerns the gene EGFR and lung cancer.